Home LiteratureArticle Details
PMID: 2111548 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells.

Pancreas ·Vol. 5 ·No. 3 ·1990-05-00 ·Pages 267-77

Raitano AB, Scuderi P, Korc M

Abstract

The cytotoxic/cytostatic effects of recombinant human tumor necrosis factor alpha (rhTNF) and gamma interferon (rhIFN-gamma) were studied in five human pancreatic tumor cell lines. During a 48-h incubation, MIA PaCa-2 cells were most sensitive to rhTNF (56% cytotoxicity, 500 U/ml), T3M4 cells were most sensitive to rhIFN-gamma (54% cytostasis, 250 U/ml), and ASPC-1 and COLO 357 cells were most sensitive to the combination of rhTNF and rhIFN-gamma (56 and 55% cytotoxicity, respectively, 250 U/ml of each cytokine). The PANC-1 cells were relatively insensitive to either the individual or the combined effects of these cytokines. All five cell lines exhibited specific, high-affinity receptors for 125I-labeled rhTNF (480-8,610 sites/cell) and rhIFN-gamma (2,050-6,280 sites/cell). The MIA PaCa-2 cells, which were the most sensitive to the inhibitory effects of rhTNF, also possessed the largest number of 125I rhTNF receptors; all other cell lines had a relatively low number of binding sites and low sensitivity. In contrast, no direct correlation could be made between the number of IFN-gamma binding sites and inhibitory sensitivity in any of the cell lines. Incubation of COLO 357 cells at 37 degrees C with either 125I rhTNF or 125I rhINF-gamma led to internalization of the respective 125I-labeled ligand. Our findings document the presence of cytokine receptors in human pancreatic carcinoma cells and suggest that postreceptor events rather than differences in receptor number or affinity more likely govern the responsiveness of pancreatic cancer cells to TNF and IFN-gamma.

MeSH Terms
Cell Survival/drug effects Humans Interferon-gamma/metabolism,pharmacology Pancreatic Neoplasms/drug therapy,metabolism Protein Binding Recombinant Proteins/metabolism,pharmacology Tumor Cells, Cultured Tumor Necrosis Factor-alpha/metabolism,pharmacology
Chemicals
Recombinant Proteins Tumor Necrosis Factor-alpha Interferon-gamma
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Raitano A B
Department of Microbiology, Arizona Cancer Center, University of Arizona School of Medicine, Tucson.
Scuderi P
Korc M
Article Info
Journal
Pancreas
Abbr.
Pancreas
ISSN
0885-3177
Published
1990-05-00
Pages
267-77
Language
English
Region
United States
NLM ID
8608542
Subset
IM
Grants
NCI NIH HHS · CA-09213 · United States
NCI NIH HHS · CA-21839 · United States
NCI NIH HHS · CA-40162 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com